Match!
Miguel Cainzos-Achirica
Johns Hopkins University
78Publications
14H-index
537Citations
Publications 78
Newest
#1Joan FortunyH-Index: 12
#2Alicia Gilsenan (RTP: Research Triangle Park)H-Index: 10
Last.Elizabeth B. Andrews (RTP: Research Triangle Park)H-Index: 21
view all 15 authors...
Introduction Given prior safety experience with other 5-HT4 agonists for chronic constipation, an observational, population-based cohort study in five data sources from Germany, Sweden, and the UK was conducted to evaluate the cardiovascular safety of prucalopride.
1 CitationsSource
#1Alicia Gilsenan (RTP: Research Triangle Park)H-Index: 10
#2Joan FortunyH-Index: 12
Last.Elizabeth B. Andrews (RTP: Research Triangle Park)H-Index: 21
view all 17 authors...
Introduction The serotonin 5-HT4 receptor agonist prucalopride is approved in the European Union for the treatment of chronic constipation. This offered the unique opportunity to include real-world observational data on cardiovascular safety in the new drug application for approval of prucalopride in the USA.
1 CitationsSource
A reduced estimated glomerular filtration rate (eGFR) has been described as a predictor of heart failure (HF). However, the increased risk across eGFR categories has not been fully evaluated, which is especially relevant in older individuals in whom both the prevalence of HF and decreased eGFR are higher. Furthermore, this association has not been studied in Mediterranean populations, where coronary heart disease (CHD), a frequent cause of HF, has a low prevalence. We performed a retrospective c...
Source
#2Zeina DardariH-Index: 14
Last.Michael J. BlahaH-Index: 52
view all 11 authors...
Source
#1Joan FornsH-Index: 25
Last.Manel Pladevall (HFHS: Henry Ford Health System)H-Index: 19
view all 15 authors...
1 CitationsSource
Last.Xavier Pintó (University of Barcelona)H-Index: 41
view all 15 authors...
Abstract South Asian (SA) individuals represent a large, growing population in a number of European countries. These individuals, particularly first-generation SA immigrants, are at higher risk of developing type 2 diabetes, atherogenic dyslipidaemia, and coronary heart disease than most other racial/ethnic groups living in Europe. SAs also have an increased risk of stroke compared to European-born individuals. Despite a large body of conclusive evidence, SA-specific cardiovascular health promot...
Source
#1Usama Bilal (Drexel University)H-Index: 12
#2Miguel Cainzos-Achirica (Johns Hopkins University)H-Index: 14
Last.Emili VelaH-Index: 13
view all 7 authors...
Abstract We evaluated the association between individual-level socioeconomic status (SES), life expectancy, and mortality, in adult men and women from the general population living in Catalonia, a universal healthcare coverage setting. We used the Catalan Health Surveillance System database, which includes individual-level information on sociodemographic characteristics and mortality for all residents of Catalonia (Spain). We categorized individuals as high, medium, low or very low SES based on ...
Source
#1Sonia Ruiz-Bustillo (Autonomous University of Barcelona)H-Index: 1
#2Consol Ivern (Autonomous University of Barcelona)H-Index: 1
Last.Josep Comin-Colet (University of Barcelona)H-Index: 23
view all 11 authors...
Background and aims:Lack of achievement of secondary prevention objectives in patients with ischaemic heart disease remains an unmet need in this patient population. We aimed at evaluating the six-...
Source
Source
#1Joan FornsH-Index: 25
#2Anton PottegårdH-Index: 22
Last.Johan Reutfors (Karolinska University Hospital)H-Index: 14
view all 19 authors...
Background We aimed to describe patterns of use and characteristics of 10 commonly used antidepressants for the period 2009–2014 in Denmark, Germany, Spain, and Sweden. Methods Adult initiators from 2009 to 2014 of each study antidepressant were identified in four countries using five data sources: the Danish National registers, GePaRD (Germany), EpiChron (Aragon, Spain), SIDIAP (Catalonia, Spain), and the Swedish National Registers. The study included 10 study antidepressants: citalopram, escit...
1 CitationsSource
12345678